Literature DB >> 15735690

SLUG in cancer development.

Pedro Antonio Pérez-Mancera1, Inés González-Herrero, María Pérez-Caro, Noelia Gutiérrez-Cianca, Teresa Flores, Alfonso Gutiérrez-Adán, Belén Pintado, Manuel Sánchez-Martín, Isidro Sánchez-García.   

Abstract

The SNAIL-related zinc-finger transcription factor, SLUG (SNAI2), is critical for the normal development of neural crest-derived cells and loss-of-function SLUG mutations have been proven to contribute to piebaldism and Waardenburg syndrome type 2 in a dose-dependent fashion. While aberrant induction of SLUG has been documented in cancer cells, relatively little is known about the consequences of SLUG overexpression in malignancy. To investigate the potential role of SLUG overexpression in development and in cancer, we generated mice carrying a tetracycline-repressible Slug transgene. These mice were morphologically normal at birth, and developed mesenchymal tumours (leukaemia and sarcomas) in almost all cases examined. Suppression of the Slug transgene did not rescue the malignant phenotype. Furthermore, the BCR-ABL oncogene, which induces Slug expression in leukaemic cells, did not induce leukaemia in Slug-deficient mice, implicating Slug in BCR-ABL leukaemogenesis in vivo. Overall, the findings indicate that while Slug overexpression is not sufficient to cause overt morphogenetic defects in mice, they demonstrate a specific and critical role for Slug in the pathogenesis of mesenchymal tumours.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15735690     DOI: 10.1038/sj.onc.1208505

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  50 in total

1.  New functions for the Snail family of transcription factors: Two-faced proteins.

Authors:  Jesús Pérez-Losada; Isidro Sanchez-Garcia
Journal:  Cell Cycle       Date:  2010-07-15       Impact factor: 4.534

2.  Clinicopathologic significance of slug expression in human intrahepatic cholangiocarcinoma.

Authors:  Ke-Jun Zhang; Bing-Yuan Zhang; Kun-Peng Zhang; Li-Min Tang; Shi-Song Liu; Dong-Ming Zhu; Dian-Liang Zhang
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

3.  Slug/SNAI2 regulates cell proliferation and invasiveness of metastatic prostate cancer cell lines.

Authors:  Modjtaba Emadi Baygi; Zahra-Soheila Soheili; Frank Essmann; Abdolkhaleg Deezagi; Rainer Engers; Wolfgang Goering; Wolfgang A Schulz
Journal:  Tumour Biol       Date:  2010-05-27

4.  SLUG is a direct transcriptional repressor of PTEN tumor suppressor.

Authors:  Berna Uygur; Katrina Abramo; Evgenia Leikina; Calvin Vary; Lucy Liaw; Wen-Shu Wu
Journal:  Prostate       Date:  2015-03-01       Impact factor: 4.104

5.  Overexpression of Snai3 suppresses lymphoid- and enhances myeloid-cell differentiation.

Authors:  Timothy Dahlem; Scott Cho; Gerald J Spangrude; Janis J Weis; John H Weis
Journal:  Eur J Immunol       Date:  2012-04       Impact factor: 5.532

6.  A critical role for Cadherin6B in regulating avian neural crest emigration.

Authors:  E G Coles; L A Taneyhill; M Bronner-Fraser
Journal:  Dev Biol       Date:  2007-10-05       Impact factor: 3.582

7.  NOV promoted the growth and migration of pancreatic cancer cells.

Authors:  Lei Cui; Rong Xie; Shenchun Dang; Qing Zhang; Shengfa Mao; Jixiang Chen; Jianguo Qu; Jianxin Zhang
Journal:  Tumour Biol       Date:  2013-11-21

8.  Slug deficiency enhances self-renewal of hematopoietic stem cells during hematopoietic regeneration.

Authors:  Yan Sun; Lijian Shao; Hao Bai; Zack Z Wang; Wen-Shu Wu
Journal:  Blood       Date:  2009-12-23       Impact factor: 22.113

9.  The EMT regulator ZEB2 is a novel dependency of human and murine acute myeloid leukemia.

Authors:  Hubo Li; Brenton G Mar; Huadi Zhang; Rishi V Puram; Francisca Vazquez; Barbara A Weir; William C Hahn; Benjamin Ebert; David Pellman
Journal:  Blood       Date:  2016-10-18       Impact factor: 22.113

10.  SLUG silencing increases radiosensitivity of melanoma cells in vitro.

Authors:  Chiara Arienti; Anna Tesei; Silvia Carloni; Paola Ulivi; Antonino Romeo; Giulia Ghigi; Enrico Menghi; Anna Sarnelli; Elisabetta Parisi; Rosella Silvestrini; Wainer Zoli
Journal:  Cell Oncol (Dordr)       Date:  2012-12-19       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.